Biotech · Private company · New York, NY, US
Fesariustherapeutics, Inc.
Track this companyFree. Adds Fesariustherapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards5
- An Antimicrobial Dermal Regeneration Template for application in challenging wound environmentsFiscal year 2025 · $349.9KNIH RePORTER 1R43GM161193-01 · fetched Nov 12, 2026
- An advanced dermal regeneration scaffold for skin loss due to burn woundsFiscal year 2024 · $349.3KNIH RePORTER 1R43GM156172-01 · fetched Nov 12, 2026
- An Advanced Dermal Regeneration Scaffold for Reconstructive SurgeryFiscal year 2024 · $50KNIH RePORTER 3R44AR082787-01A1S1 · fetched Nov 12, 2026
- An Advanced Dermal Regeneration Scaffold for Reconstructive SurgeryFiscal year 2024 · $953.5KNIH RePORTER 5R44AR082787-02 · fetched Nov 12, 2026
- DermiSphere™: An Advanced Dermal Regeneration Scaffold for Reconstructive Surgery, CRPFiscal year 2024 · $396.7KNIH RePORTER 5SB1AR076301-05 · fetched Nov 12, 2026